Update
$HOOKIPA Pharma(HOOK.US$ HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for Hb-200 in Combination With Pembrolizumab! EXPECTED to enroll first patients by Q4
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
STD0313 : slow mover today.....you still in?
TrytosaveabitOP STD0313: It is! And yeppers I am still in! As long as I don’t break my cost positioning? Im swinging it until my first scale out ( of which I hope many ) is 1.13! GL and big profits to ya